Literature DB >> 24711103

Fetal persistent left superior vena cava in cases with and without chromosomal anomalies.

Liu Du1, Hong-Ning Xie, Yun-Xiao Zhu, Li-Juan Li, Ruan Peng, Ju Zheng.   

Abstract

OBJECTIVES: The objectives of this study are to determine and compare the prevalence of persistent left superior vena cava (PLSVC) in chromosomally normal and abnormal fetuses and to evaluate the potential of PLSVC as a screening marker for chromosomal abnormalities.
METHODS: Women undergoing routine fetal sonographic examinations were evaluated once for the presence of PLSVC. PLSVC was diagnosed on the basis of the identification of an additional vessel in the left of the pulmonary artery in a three-vessel trachea view. Associated abnormalities, karyotypes, and outcomes were analyzed.
RESULTS: A total of 164 (0.7%, 164/25 171) cases of PLSVC were detected and successfully followed-up. The detection rates were 0.5% (81/17 535) and 1.1% (83/7636) in the low-risk and high-risk cases, respectively. The incidence of PLSVC was lower among the chromosomally or clinically normal (0.4%, 110/24 914) compared with chromosomally abnormal fetuses (7.8%, 20/257, p < 0.001). Additional defects were identified in 90% (18/20) of the PLSVC fetuses with chromosomal anomalies, a rate that was higher than those fetuses with chromosomal normal (61.8%, 68/110).
CONCLUSIONS: Persistent left superior vena cava is more common among chromosomally abnormal than normal fetuses, and PLSVC fetuses with other defects are more highly associated with chromosomal disorders than isolated PLSVC fetuses. Isolated PLSVC is a benign vascular anomaly and may not affect outcomes.
© 2014 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24711103     DOI: 10.1002/pd.4380

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  8 in total

1.  Left Superior Vena Cava in the Fetus: A Rarely Isolated Anomaly.

Authors:  Anne-Frédérique Minsart; Isabelle Boucoiran; Marie-Ange Delrue; François Audibert; Sylvia Abadir; Chantale Lapierre; Emmanuelle Lemyre; Marie-Josée Raboisson
Journal:  Pediatr Cardiol       Date:  2019-11-13       Impact factor: 1.655

Review 2.  Left superior vena cava: cross-sectional imaging overview.

Authors:  Nihal M Batouty; Donia M Sobh; Basma Gadelhak; Hoda M Sobh; Walaa Mahmoud; Ahmed M Tawfik
Journal:  Radiol Med       Date:  2019-12-10       Impact factor: 3.469

3.  Gradual diagnosis and clinical importance of prenatally detected persistent left superior vena cava with absent right superior vena cava - a case report and literature review.

Authors:  Oskar Sylwestrzak; Maria Respondek-Liberska
Journal:  J Ultrason       Date:  2020-06-15

4.  Waardenburg Syndrome and Left Persistent Superior Vena Cava.

Authors:  Driss Raissi; Alexander Christie; Kimberly Applegate
Journal:  J Clin Imaging Sci       Date:  2018-11-15

5.  Prenatal diagnosis of persistent left superior vena cava: a retrospective study of associated congenital anomalies.

Authors:  Mehmet Özsürmeli; Selim Büyükkurt; Mete Sucu; Erol Arslan; Çiğdem Akçabay; Selahattin Mısırlıoğlu; Masum Kayapınar; Nazan Özbarlas; Süleyman Cansun Demir; Cüneyt Evrüke
Journal:  Turk J Obstet Gynecol       Date:  2019-03-27

6.  Catheterization in a patient with end-stage renal disease through persistent left superior vena cava: a rare case report and literature review.

Authors:  Huisi He; Bingyang Li; Yiyi Ma; Yuqiang Zhang; Chaoyang Ye; Changlin Mei; Shengqiang Yu; Bing Dai; Yawei Liu
Journal:  BMC Nephrol       Date:  2019-06-04       Impact factor: 2.388

7.  Persistent Left Superior Vena Cava Significance in Prenatal Diagnosis-Case Series.

Authors:  Mircea-Octavian Poenaru; Bashar Haj Hamoud; Romina-Marina Sima; Ionut-Didel Valcea; Radu Chicea; Liana Ples
Journal:  J Clin Med       Date:  2022-07-12       Impact factor: 4.964

8.  Clinical characteristics of prenatally diagnosed persistent left superior vena cava in low-risk pregnancies.

Authors:  Eun-Young Choi; Soo-Kyung Hong; Na-Yeong Jeong
Journal:  Prenat Diagn       Date:  2016-03-27       Impact factor: 3.050

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.